Upendra Marathi, Ph.D.
Vice President

Upendra is also at MediGen Group which seeded and started PLx Pharma. Previously, he was with Momentum Bio Ventures where he led the venture development team. He was also with BCM Technologies, the venture subsidiary and incubator for the Baylor College of Medicine where he was involved in the founding and launch of several biotechnology companies, including drug discovery, bio-tool and pharmaceutical companies. The companies have raised over $27 million in venture financing. Prior to BCMT, Upendra was a post-doctoral fellow at St. Jude Children’s Research Hospital and University of Texas M.D. Anderson Cancer Center. He has nearly 10 years of drug development and molecular biology experience. His work has culminated in three novel means to treat cancer that are in Phase I and III clinical trials. He serves on the Faculty of the Jones School of Management at Rice University.